4

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: October 20, 2015
Period of Report: October 19, 2015
Accession Number: 0001546927-15-000263

View Document ↗ View on SEC.gov ↗